Global Electroretinography (EGR) Device Market Size By Type (Fixed ERG, Portable ERG), By Application (Clinical Use, For Research), By Region, And Segment Forecasts, 2023 to 2032

The Global Electroretinography (EGR) Device Market was valued at USD 42.5 million in 2023 and is projected to reach USD 74.8 million by 2031, growing at a CAGR of 7.2% during the forecast period from 2023 to 2031. The growth is driven by the increasing prevalence of retinal disorders, rising geriatric population, and technological advancements in ophthalmic diagnostics. Electroretinography devices are essential for assessing retinal function and diagnosing conditions such as retinitis pigmentosa, diabetic retinopathy, and macular degeneration. With growing awareness about eye health and early diagnosis, the demand for accurate and non-invasive retinal diagnostic tools like EGR devices is set to surge.

Drivers:

Increasing Incidence of Retinal Disorders:

The rise in eye diseases due to aging populations and chronic conditions such as diabetes is significantly boosting demand for electroretinography devices for early detection and monitoring.

Technological Advancements:

Improvements in diagnostic precision, portability, and user-friendly interfaces in EGR devices are attracting wider adoption across clinics and research institutions.

Growing Geriatric Population:

Elderly individuals are more susceptible to vision disorders, driving the need for routine retinal screening and contributing to market expansion.

Restraints:

High Cost of Devices and Procedures:

Electroretinography equipment is relatively expensive, which may limit adoption in low-income and rural healthcare settings.

Limited Awareness in Emerging Markets:

Despite growing incidence of retinal diseases, lack of awareness and inadequate healthcare infrastructure in developing regions can hinder market penetration.

Opportunity:

Expansion into Emerging Markets:

Rapid urbanization, improving healthcare access, and increased healthcare expenditure in countries like India and Brazil offer significant growth potential for EGR device manufacturers.

Integration with AI and Digital Imaging:

The application of artificial intelligence for retinal diagnostics and the integration of EGR data with digital imaging and electronic health records represent transformative opportunities.

Market by System Type Insights:

The Full-Field Electroretinography (ffERG) segment dominated the market in 2023 due to its widespread use in evaluating global retinal function. However, the Multifocal Electroretinography (mfERG) segment is expected to grow at the highest CAGR, owing to its effectiveness in assessing localized retinal dysfunction and its applications in drug toxicity screening and clinical trials.

Market by End-Use Insights:

Hospitals held the largest market share in 2023, benefiting from the availability of advanced diagnostic equipment and skilled professionals. However, the Ophthalmic Clinics segment is projected to witness robust growth, driven by the trend towards outpatient services and the proliferation of specialized eye care centers.

Market by Regional Insights:

North America led the global EGR device market in 2023, backed by a strong healthcare infrastructure, high awareness levels, and supportive reimbursement policies. Asia-Pacific is expected to record the highest growth rate during the forecast period, fueled by an aging population, increasing healthcare investments, and improved access to diagnostic services in countries like China and India.

Competitive Scenario:

Key players in the global EGR device market include LKC Technologies, Inc., Diagnosys LLC, Roland Consult, Metrovision, CSO Italia, and Konan Medical USA, Inc. These companies are investing in R&D to enhance device capabilities, entering strategic partnerships, and expanding their geographic presence to strengthen their market position.

Scope of Work – Global Electroretinography (EGR) Device Market

Report Metric Details

Market Size (2023) USD 42.5 million

Projected Market Size (2031) USD 74.8 million

CAGR (2023–2031) 7.2%

Market Segments System Type (ffERG, mfERG, pERG), End-Use (Hospitals, Clinics, Research Centers), Region

Growth Drivers Increasing incidence of retinal diseases, growing geriatric population, technological advancements

Opportunities AI integration, emerging markets expansion

Key Market Developments:

2023: LKC Technologies introduced a next-gen wireless electroretinography device designed for faster, more comfortable patient testing.

2024: Diagnosys LLC announced a collaboration with a leading eye care network to deploy portable EGR units across rural clinics.

2025: Roland Consult launched an integrated EGR-visual evoked potential (VEP) system aimed at comprehensive neuro-ophthalmic diagnostics.

FAQs:

1) What is the current market size of the Global Electroretinography (EGR) Device Market?

The market size was USD 42.5 million in 2023.

2) What is the major growth driver of the Global Electroretinography (EGR) Device Market?

The primary growth driver is the increasing prevalence of retinal diseases and aging population.

3) Which is the largest region during the forecast period in the Global Electroretinography (EGR) Device Market?

North America holds the largest market share, driven by advanced healthcare infrastructure and high disease awareness.

4) Which segment accounted for the largest market share in the Global Electroretinography (EGR) Device Market?

The Full-Field Electroretinography (ffERG) segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Electroretinography (EGR) Device Market?

Key players include LKC Technologies, Diagnosys LLC, Roland Consult, Metrovision, CSO Italia, and Konan Medical USA, Inc.